PET of insulinoma using 18F-FBEM-EM3106B, a new GLP-1 analogue

Molecular Pharmaceutics

Volumn 8, Issue 5, 2011, Pages 1775-1782

  Gao, Haokao ^a,b   Niu, Gang ^a   Yang, Min ^a   Quan, Qimeng ^a   Ma, Ying ^a   Murage, Eunice N ^c   Ahn, Jung Mo ^c   Kiesewetter, Dale O ^a   Chen, Xiaoyuan ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

18F FBEM; bicyclic GLP 1 analogue; glucagon like peptide 1 receptor; insulinoma; PET

Indexed keywords

EM 3106 B; FLUORINE 18; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; N 2 (4 FLUOROBENZAMIDO)ETHYLMALEIMIDE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 (7 36); GLUCAGON LIKE PEPTIDE RECEPTOR; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE 1 (7-36); GLUCAGON-LIKE PEPTIDE RECEPTOR; LACTAM; MALEIMIDE DERIVATIVE; N (2 (4 18F FLUOROBENZAMIDO)ETHYL)MALEIMIDE; N 2 (4 FLUOROBENZAMIDO)ETHYLMALEIMIDE EM 3106B; N-(2-(4-18F-FLUOROBENZAMIDO)ETHYL)MALEIMIDE; N-2-(4-FLUOROBENZAMIDO)ETHYLMALEIMIDE-EM 3106B; PEPTIDE; PEPTIDE FRAGMENT; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; DRUG DISTRIBUTION; DRUG UPTAKE; EX VIVO STUDY; INSULINOMA; MELANOMA; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; ANIMAL; CHEMISTRY; DRUG POTENTIATION; DRUG STABILITY; FEMALE; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR IMAGING; NUDE MOUSE; PANCREAS ISLET; PATHOLOGY; TISSUE DISTRIBUTION; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE; WHOLE BODY IMAGING;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CONTRAST MEDIA; DRUG STABILITY; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULINOMA; ISLETS OF LANGERHANS; LACTAMS; MALEIMIDES; MICE; MICE, NUDE; MOLECULAR IMAGING; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, GLUCAGON; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

EID: 80053493999     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200141x     Document Type: Article

References (22)

1. Chatziioannou, A.; Kehagias, D.; Mourikis, D.; Antoniou, A.; Limouris, G.; Kaponis, A.; Kavatzas, N.; Tseleni, S.; Vlachos, L. Imaging and localization of pancreatic insulinomas Clin. Imaging 2001, 25 (4) 275-83 (Pubitemid 32807625)
2. Ramage, J. K.; Davies, A. H.; Ardill, J.; Bax, N.; Caplin, M.; Grossman, A.; Hawkins, R.; McNicol, A. M.; Reed, N.; Sutton, R.; Thakker, R.; Aylwin, S.; Breen, D.; Britton, K.; Buchanan, K.; Corrie, P.; Gillams, A.; Lewington, V.; McCance, D.; Meeran, K.; Watkinson, A. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours Gut 2005, 54 (Suppl. 4) iv1-16
3. Modlin, I. M.; Tang, L. H. Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today) Gastroenterology 1997, 112 (2) 583-90 (Pubitemid 27078846)
4. 3]-octreotide: the Rotterdam experience with more than 1000 patients Eur. J. Nucl. Med. 1993, 20 (8) 716-31 (Pubitemid 23284773)
5. Jackson, J. E. Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours Best Pract. Res., Clin. Endocrinol. Metab. 2005, 19 (2) 229-39 (Pubitemid 40347813)
6. Wiesli, P.; Brandle, M.; Schmid, C.; Krahenbuhl, L.; Furrer, J.; Keller, U.; Spinas, G. A.; Pfammatter, T. Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinemic hypoglycemia: potential and limitations J. Vasc. Interv. Radiol. 2004, 15 (11) 1251-6 (Pubitemid 39487855)
7. Reubi, J. C.; Waser, B. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting Eur. J. Nucl. Med. Mol. Imaging 2003, 30 (5) 781-93 (Pubitemid 36612963)
8. Gotthardt, M.; Fischer, M.; Naeher, I.; Holz, J. B.; Jungclas, H.; Fritsch, H. W.; Behe, M.; Goke, B.; Joseph, K.; Behr, T. M. Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results Eur. J. Nucl. Med. Mol. Imaging 2002, 29 (5) 597-606 (Pubitemid 34439319)
9. 2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting J. Nucl. Med. 2006, 47 (12) 2025-33 (Pubitemid 47558899)
10. 2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma Clin. Cancer Res. 2007, 13 (12) 3696-705 (Pubitemid 46955134)
11. Wild, D.; Macke, H.; Christ, E.; Gloor, B.; Reubi, J. C. Glucagon-like peptide 1-receptor scans to localize occult insulinomas N. Engl. J. Med. 2008, 359 (7) 766-8
12. Christ, E.; Wild, D.; Forrer, F.; Brandle, M.; Sahli, R.; Clerici, T.; Gloor, B.; Martius, F.; Maecke, H.; Reubi, J. C. Glucagon-like peptide-1 receptor imaging for localization of insulinomas J. Clin. Endocrinol. Metab. 2009, 94 (11) 4398-405
13. Wild, D.; Wicki, A.; Mansi, R.; Behe, M.; Keil, B.; Bernhardt, P.; Christofori, G.; Ell, P. J.; Macke, H. R. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT J. Nucl. Med. 2010, 51 (7) 1059-67
14. Murage, E. N.; Gao, G.; Bisello, A.; Ahn, J. M. Development of potent glucagon-like peptide-1 agonists with high enzyme stability via introduction of multiple lactam bridges J. Med. Chem. 2010, 53 (17) 6412-20
15. 18F]FBEM: A thiol reactive synthon for radiofluorination of peptides and proteins Appl. Radiat. Isot. 2011, 69 (2) 410-4
16. Sebokova, E.; Christ, A. D.; Wang, H.; Sewing, S.; Dong, J. Z.; Taylor, J.; Cawthorne, M. A.; Culler, M. D. Taspoglutide, an analog of human glucagon-like Peptide-1 with enhanced stability and in vivo potency Endocrinology 2010, 151 (6) 2474-82
17. 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET Eur J. Nucl. Med. Mol. Imaging 2010, 37 (7) 1345-55
18. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals Contrast Media Mol. Imaging 2008, 3 (2) 67-77
19. Horton, K. M.; Hruban, R. H.; Yeo, C.; Fishman, E. K. Multi-detector row CT of pancreatic islet cell tumors Radiographics 2006, 26 (2) 453-64 (Pubitemid 43515317)
20. Ahren, B. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes Nat. Rev. Drug Discovery 2009, 8 (5) 369-85
21. Korner, M.; Stockli, M.; Waser, B.; Reubi, J. C. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting J. Nucl. Med. 2007, 48 (5) 736-43 (Pubitemid 47604973)
22. Pattou, F.; Kerr-Conte, J.; Wild, D. GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle N. Engl. J. Med. 2010, 363 (13) 1289-90